p53 and angiogenesis in non-small-cell lung cancer
Open Access
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (5) , 850-851
- https://doi.org/10.1038/bjc.1998.138
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expressionBritish Journal of Cancer, 1997
- Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancerBritish Journal of Cancer, 1997
- Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.1996
- PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCERThe Journal of Pathology, 1996
- Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.Journal of Clinical Oncology, 1995
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Studies on Clinicopathological Features of Lung Cancer Patients with K-ras/p53 Gene Alterations: Comparison between Younger and Older GroupsOncology, 1995
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994
- Antibody for detecting p53 protein by immunohistochemistry in normal tissues.Journal of Clinical Pathology, 1994
- The relationship of p53 immunostaining to survival in carcinoma of the lungBritish Journal of Cancer, 1992